Answers are grounded in this paper and cite their sources.
Tumor acidosis causes resistance to immune checkpoint blockade (ICB) immunotherapy. We have identified a “pH-sensitizer” that increases the extracellular pH of the tumor microenvironment, improving immunogenicity and tumor control with ICB. AcidoCEST MRI can measure the extracellular pH of the tumor microenvironment. We used acidoCEST MRI to correlate the increase in tumor pHe immediately caused by the pH-senstizer with the tumor volume at study endpoint, in a pre-clinical model of breast cancer. These results show that acidoCEST MRI can contribute to predicting the outcome of immunotherapy.
No takes yet. Share an insight, caveat, or question.
Chin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: